SCHEMBL9079293

SCHEMBL9079293

Cc1cc(C)c(C(=O)P(=O)(OC(C)C)OC(C)C)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MCOLN3 Q8TDD5 1/20 0.38
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
TAS1R3 Q7RTX0 4/20 0.36
TAS1R1 Q7RTX1 4/20 0.36
TAS1R2 Q8TE23 4/20 0.36
LMNA P02545 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
HMGCR P04035 1/20 0.35
CTSA P10619 1/20 0.34
ACHE P22303 1/20 0.34
HTT P42858 1/20 0.33
KDM4E B2RXH2 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13811174 0.82 KMT2A (0.35) HPGDNPSR1MCOLN3KMT2AALDH1A1
SCHEMBL13811185 0.81 HPGD (0.37) HPGDNPSR1MCOLN3KMT2AALDH1A1
SCHEMBL10092048 0.80 SMN1; SMN2 (0.38) HPGDNPSR1MCOLN3KMT2AALDH1A1
SCHEMBL6904528 0.79 TAS1R3 (0.39) HPGDNPSR1MCOLN3KMT2AALDH1A1
SCHEMBL155284 0.77 ALDH1A1 (0.46) HPGDNPSR1MCOLN3KMT2AALDH1A1
SCHEMBL9875401 0.76 HPGD (0.36) HPGDNPSR1MCOLN3KMT2AALDH1A1
SCHEMBL6470177 0.76 HPGD (0.41) HPGDNPSR1MCOLN3KMT2AALDH1A1
SCHEMBL68708 0.75 SMN1; SMN2 (0.41) HPGDKMT2AALDH1A1MAPTTAS1R3
SCHEMBL8982009 0.75 TAS1R3 (0.36) HPGDNPSR1MCOLN3KMT2AALDH1A1
SCHEMBL3195966 0.74 TAS1R3 (0.43) HPGDNPSR1MCOLN3KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090142672-A1 OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM FUJIFILM CORPORATION (JP) 2009-06-04 US disclosed
US-20090142672-A1 OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM FUJIFILM CORPORATION (JP) 2009-06-04 US disclosed
US-5494645-A UV-CURING OF A COATED COMPOSITION OF COLLOICAL SILICA, AN UNSATURATED SILANE, A POLYACRYLOYLOXY-CONTAINING COMPOUND, A HYDROXY- AND ACRYLOYLOXY-CONTAINING TRIAZINE AND AN ACYLPHOSPHINE-TYPE PHOTOINITIATOR MITSUBISHI RAYON CO., LTD. (JP) 1996-02-27 US disclosed
US-5449702-A Coating composition and process for producing abrasion-resistant synthetic resin molded articles MITSUBISHI RAYON CO., LTD. (JP) 1995-09-12 US disclosed
US-4985472-A ACRYLATED POLYISOCYANATE MITSUBISHI RAYON COMPANY, LTD. (JP) 1991-01-15 US disclosed
EP-0313665-A1 ACTINIC RADIATION-CURABLE COMPOSITION FOR CAST POLYMERIZATION AND PRODUCT OF CAST POLYMERIZATION MITSUBISHI RAYON CO., LTD. (JP) 1989-05-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090142672-A1 OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM CRY1, CRY2, CACNA1B HPGD 1179/4885NPSR1 2174/4885MCOLN3 1391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.